Asianet Newsable on MSN

Verastem Stock Ignites Retail Buzz After Early Cancer Drug Data Show Tumor Reduction, Mild Side Effects

Verastem reported early trial data showing its experimental oral therapy targeting KRAS-driven cancers was well-tolerated, ...